Skip to main content

Table 1 Matrix of pharmacological interactions tested on amastigotes of Trypanosoma cruzi or J774A.1 macrophage cell

From: Immunomodulatory, trypanocide, and antioxidant properties of essential oil fractions of Lippia alba (Verbenaceae)

Mixture

Factorial combinations IC50 or CC50 Values

Equivalent Compound Concentration

ACT1

ACT2

BZN

ACT1 (μg/mL)

ACT2 (μg/mL)

BZN (μg/mL)

1

0

8X IC50/CC50

 

640/1704

 

2

½X IC50/CC50

4X IC50/CC50

 

22.5/229

320/852

 

3

1X IC50/CC50

2X IC50/CC50

 

45/458

160/426

 

4

2X IC50/CC50

1X IC50/CC50

 

90/916

80/213

 

5

4X IC50/CC50

½X IC50/CC50

 

180/1832

40/106.5

 

6

8X IC50/CC50

0

 

360/3664

 

7

0

 

8X IC50/CC50

 

384/2388

8

½X IC50−CC50

 

4X IC50/CC50

22.5/229

 

192/1194

9

1X IC50/CC50

 

2X IC50/CC50

45/458

 

96/597

10

2X IC50/CC50

 

1X IC50/CC50

90/916

 

48/298.5

11

4X IC50/CC50

 

½X IC50/CC50

180/1832

 

24/149.3

12

8X IC50/CC50

 

0

360/3664

 

  1. ACT1 limonene-enriched fraction from Carvone-chemotype of Lippia alba, ACT2 citral/caryophyllene oxide enriched fraction from Citral-chemotype of Lippia alba, BZN Benznidazole, X Multiplier, IC50 Inhibitory Concentration 50, CC50 Cytotoxic Concentration 50